Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration
Authors
Keywords
Folate, HuR, Lung cancer, Nanoparticle, Oncoprotein, siRNA, Targeting
Journal
JOURNAL OF NANOBIOTECHNOLOGY
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-06-22
DOI
10.1186/s12951-016-0201-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delivery of Therapeutics Targeting the mRNA-Binding Protein HuR Using 3DNA Nanocarriers Suppresses Ovarian Tumor Growth
- (2016) Yu-Hung Huang et al. CANCER RESEARCH
- HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells
- (2016) C. Romeo et al. MOLECULAR CANCER RESEARCH
- HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer
- (2015) R Muralidharan et al. CANCER GENE THERAPY
- Nanoparticle-mediated delivery of siRNA for effective lung cancer therapy
- (2015) Young-Dong Kim et al. Nanomedicine
- CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis
- (2015) Shu Zhang et al. PLoS One
- Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity
- (2015) Janani Panneerselvam et al. Oncotarget
- IL-24 Inhibits Lung Cancer Cell Migration and Invasion by Disrupting The SDF-1/CXCR4 Signaling Axis
- (2015) Janani Panneerselvam et al. PLoS One
- MiR-291b-3p Induces Apoptosis in Liver Cell Line NCTC1469 by Reducing the Level of RNA-binding Protein HuR
- (2014) Jun Guo et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Multiple Functions of the RNA-Binding Protein HuR in Cancer Progression, Treatment Responses and Prognosis
- (2013) Jun Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Delivery materials for siRNA therapeutics
- (2013) Rosemary Kanasty et al. NATURE MATERIALS
- Signaling through cyclin D-dependent kinases
- (2013) Y J Choi et al. ONCOGENE
- High Expression of HuR in Cytoplasm, but Not Nuclei, Is Associated with Malignant Aggressiveness and Prognosis in Bladder Cancer
- (2013) Yasuyoshi Miyata et al. PLoS One
- Recent Developments in Nanoparticle-Based siRNA Delivery for Cancer Therapy
- (2013) Jong-Min Lee et al. Biomed Research International
- Targeting receptor-mediated endocytotic pathways with nanoparticles: Rationale and advances
- (2012) Shi Xu et al. ADVANCED DRUG DELIVERY REVIEWS
- Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans
- (2012) Charles Lu et al. PLoS One
- HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium
- (2011) T Kurosu et al. BRITISH JOURNAL OF CANCER
- The RNA-Binding Protein HuR Promotes Glioma Growth and Treatment Resistance
- (2011) N. Filippova et al. MOLECULAR CANCER RESEARCH
- Delivery of siRNA Therapeutics: Barriers and Carriers
- (2010) Jie Wang et al. AAPS Journal
- Cytoplasmic HuR expression correlates with angiogenesis, lymphangiogenesis, and poor outcome in lung cancer
- (2010) Jun Wang et al. MEDICAL ONCOLOGY
- HuR Knockdown Changes the Oncogenic Potential of Oral Cancer Cells
- (2010) W. Kakuguchi et al. MOLECULAR CANCER RESEARCH
- Elimination Pathways of Systemically Delivered siRNA
- (2010) Yuanyu Huang et al. MOLECULAR THERAPY
- HuR expression is a marker of poor prognosis in renal cell carcinoma
- (2010) Hanna Ronkainen et al. TUMOR BIOLOGY
- Regulation of Bcl-2 Expression by HuR in HL60 Leukemia Cells and A431 Carcinoma Cells
- (2009) D. Ishimaru et al. MOLECULAR CANCER RESEARCH
- Thromboxane A2 Receptors in Prostate Carcinoma: Expression and Its Role in Regulating Cell Motility via Small GTPase Rho
- (2008) D. Nie et al. CANCER RESEARCH
- Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA–PEG–folate conjugate
- (2008) Farnaz Esmaeili et al. JOURNAL OF DRUG TARGETING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More